We are analyzing https://link.springer.com/article/10.1007/s12017-009-8066-1.

Title:
microRNAs in CNS Disorders | NeuroMolecular Medicine
Description:
In recent years, there has been a shift in the conventional paradigms for transcriptional and translational regulation as extensive sequencing efforts have yielded new insights into the landscape of the human genome and transcriptome. Hundreds of non-coding regulatory RNA molecules called microRNAs (miRNAs) have been identified in the mammalian central nervous system (CNS) and are reported to mediate pivotal roles in many aspects of neuronal functions. Disruption of miRNA-based post-transcriptional regulation has been implicated in a range of CNS disorders as one miRNA is predicted to impact the expression of numerous downstream mRNA targets. The intricate molecular networks mediated by an miRNA form a robust mechanism for rapid and potent responses to cellular events throughout the development of the human brain. Recent studies have identified a molecular and ultimately pathogenic role for a subset of miRNAs in Alzheimer’s disease and schizophrenia, including the characterization of their downstream CNS mRNA targets, such as beta-secretase (BACE1) and calmodulin-dependent protein kinase II (CaMKII). Here, we present an overview of the current progress in miRNA research related to CNS disorders and also highlight the utility of LNA (locked nucleic acid)-modified oligonucleotides in the detection and modulation of miRNA activity.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

article, google, scholar, pubmed, cas, microrna, journal, disease, nucleic, research, micrornas, human, expression, brain, nature, molecular, locked, kauppinen, acid, cns, rna, schizophrenia, disorders, regulation, mirna, alzheimers, genetics, doi, biology, lna, mouse, cell, neuroscience, acids, van, privacy, cookies, content, wahlestedt, genome, regulatory, mirnas, central, nervous, system, development, current, oligonucleotides, access, rnas,

Topics {✒️}

microrna cluster mir-29a/b-1 month download article/chapter increased bace1/beta-secretase expression tdp43-positive frontotemporal dementia 22q11-deletion mouse model small regulatory rnas lna-mediated microrna silencing including mir-30a-5p snp-guided microrna map brain-derived neurotrophic factor mirna-based post-transcriptional regulation lna-modified oligonucleotide probes high-throughput mirna profiling microrna-based cancer diagnostics van der walt microrna feedback circuit full article pdf micro-rna speciation coding rnas sirna-mediated knockdown privacy choices/manage cookies mirna research related mir-659 binding-site ultimately pathogenic role van der zee van der putten adult mouse brain oligonucleotide capture probes article kocerha locked nucleic acid microrna biogenesis pathways mediate pivotal roles claes wahlestedt adult mouse forebrain nucleic acids research gene regulatory networks nuclear import pathway post-transcriptional inhibitors major risk factor locked nucleic acids brain research reviews biophysical research communications scripps research institute high-affinity targeting experimentally supported targets archival human brain microrna-328 regulate expression microrna expression profiling microrna expression profile dynamically regulated microrna

Questions {❓}

Complexity and heterogeneity: What drives the ever-changing brain in Huntington’s disease?
Locked nucleic acid oligonucleotides: The next generation of antisense agents?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:microRNAs in CNS Disorders
         description:In recent years, there has been a shift in the conventional paradigms for transcriptional and translational regulation as extensive sequencing efforts have yielded new insights into the landscape of the human genome and transcriptome. Hundreds of non-coding regulatory RNA molecules called microRNAs (miRNAs) have been identified in the mammalian central nervous system (CNS) and are reported to mediate pivotal roles in many aspects of neuronal functions. Disruption of miRNA-based post-transcriptional regulation has been implicated in a range of CNS disorders as one miRNA is predicted to impact the expression of numerous downstream mRNA targets. The intricate molecular networks mediated by an miRNA form a robust mechanism for rapid and potent responses to cellular events throughout the development of the human brain. Recent studies have identified a molecular and ultimately pathogenic role for a subset of miRNAs in Alzheimer’s disease and schizophrenia, including the characterization of their downstream CNS mRNA targets, such as beta-secretase (BACE1) and calmodulin-dependent protein kinase II (CaMKII). Here, we present an overview of the current progress in miRNA research related to CNS disorders and also highlight the utility of LNA (locked nucleic acid)-modified oligonucleotides in the detection and modulation of miRNA activity.
         datePublished:2009-06-18T00:00:00Z
         dateModified:2009-06-18T00:00:00Z
         pageStart:162
         pageEnd:172
         sameAs:https://doi.org/10.1007/s12017-009-8066-1
         keywords:
            microRNA
            CNS
            Schizophrenia
            Alzheimer’s
            LNA
            Neurosciences
            Neurology
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12017-009-8066-1/MediaObjects/12017_2009_8066_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12017-009-8066-1/MediaObjects/12017_2009_8066_Fig2_HTML.gif
         isPartOf:
            name:NeuroMolecular Medicine
            issn:
               1559-1174
               1535-1084
            volumeNumber:11
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Humana Press Inc
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jannet Kocerha
               affiliation:
                     name:Scripps Research Institute
                     address:
                        name:Department of Molecular and Integrative Neurosciences, Scripps Research Institute, Jupiter, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sakari Kauppinen
               affiliation:
                     name:Santaris Pharma
                     address:
                        name:Santaris Pharma, Horsholm, Denmark
                        type:PostalAddress
                     type:Organization
                     name:University of Copenhagen
                     address:
                        name:Department of Cellular and Molecular Medicine, Wilhelm Johannsen Centre for Functional Genome Research, University of Copenhagen, Copenhagen, Denmark
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Claes Wahlestedt
               affiliation:
                     name:Scripps Research Institute
                     address:
                        name:Department of Molecular and Integrative Neurosciences, Scripps Research Institute, Jupiter, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:microRNAs in CNS Disorders
      description:In recent years, there has been a shift in the conventional paradigms for transcriptional and translational regulation as extensive sequencing efforts have yielded new insights into the landscape of the human genome and transcriptome. Hundreds of non-coding regulatory RNA molecules called microRNAs (miRNAs) have been identified in the mammalian central nervous system (CNS) and are reported to mediate pivotal roles in many aspects of neuronal functions. Disruption of miRNA-based post-transcriptional regulation has been implicated in a range of CNS disorders as one miRNA is predicted to impact the expression of numerous downstream mRNA targets. The intricate molecular networks mediated by an miRNA form a robust mechanism for rapid and potent responses to cellular events throughout the development of the human brain. Recent studies have identified a molecular and ultimately pathogenic role for a subset of miRNAs in Alzheimer’s disease and schizophrenia, including the characterization of their downstream CNS mRNA targets, such as beta-secretase (BACE1) and calmodulin-dependent protein kinase II (CaMKII). Here, we present an overview of the current progress in miRNA research related to CNS disorders and also highlight the utility of LNA (locked nucleic acid)-modified oligonucleotides in the detection and modulation of miRNA activity.
      datePublished:2009-06-18T00:00:00Z
      dateModified:2009-06-18T00:00:00Z
      pageStart:162
      pageEnd:172
      sameAs:https://doi.org/10.1007/s12017-009-8066-1
      keywords:
         microRNA
         CNS
         Schizophrenia
         Alzheimer’s
         LNA
         Neurosciences
         Neurology
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12017-009-8066-1/MediaObjects/12017_2009_8066_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12017-009-8066-1/MediaObjects/12017_2009_8066_Fig2_HTML.gif
      isPartOf:
         name:NeuroMolecular Medicine
         issn:
            1559-1174
            1535-1084
         volumeNumber:11
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Humana Press Inc
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jannet Kocerha
            affiliation:
                  name:Scripps Research Institute
                  address:
                     name:Department of Molecular and Integrative Neurosciences, Scripps Research Institute, Jupiter, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sakari Kauppinen
            affiliation:
                  name:Santaris Pharma
                  address:
                     name:Santaris Pharma, Horsholm, Denmark
                     type:PostalAddress
                  type:Organization
                  name:University of Copenhagen
                  address:
                     name:Department of Cellular and Molecular Medicine, Wilhelm Johannsen Centre for Functional Genome Research, University of Copenhagen, Copenhagen, Denmark
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Claes Wahlestedt
            affiliation:
                  name:Scripps Research Institute
                  address:
                     name:Department of Molecular and Integrative Neurosciences, Scripps Research Institute, Jupiter, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:NeuroMolecular Medicine
      issn:
         1559-1174
         1535-1084
      volumeNumber:11
Organization:
      name:Humana Press Inc
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Scripps Research Institute
      address:
         name:Department of Molecular and Integrative Neurosciences, Scripps Research Institute, Jupiter, USA
         type:PostalAddress
      name:Santaris Pharma
      address:
         name:Santaris Pharma, Horsholm, Denmark
         type:PostalAddress
      name:University of Copenhagen
      address:
         name:Department of Cellular and Molecular Medicine, Wilhelm Johannsen Centre for Functional Genome Research, University of Copenhagen, Copenhagen, Denmark
         type:PostalAddress
      name:Scripps Research Institute
      address:
         name:Department of Molecular and Integrative Neurosciences, Scripps Research Institute, Jupiter, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jannet Kocerha
      affiliation:
            name:Scripps Research Institute
            address:
               name:Department of Molecular and Integrative Neurosciences, Scripps Research Institute, Jupiter, USA
               type:PostalAddress
            type:Organization
      name:Sakari Kauppinen
      affiliation:
            name:Santaris Pharma
            address:
               name:Santaris Pharma, Horsholm, Denmark
               type:PostalAddress
            type:Organization
            name:University of Copenhagen
            address:
               name:Department of Cellular and Molecular Medicine, Wilhelm Johannsen Centre for Functional Genome Research, University of Copenhagen, Copenhagen, Denmark
               type:PostalAddress
            type:Organization
      name:Claes Wahlestedt
      affiliation:
            name:Scripps Research Institute
            address:
               name:Department of Molecular and Integrative Neurosciences, Scripps Research Institute, Jupiter, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Molecular and Integrative Neurosciences, Scripps Research Institute, Jupiter, USA
      name:Santaris Pharma, Horsholm, Denmark
      name:Department of Cellular and Molecular Medicine, Wilhelm Johannsen Centre for Functional Genome Research, University of Copenhagen, Copenhagen, Denmark
      name:Department of Molecular and Integrative Neurosciences, Scripps Research Institute, Jupiter, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(312)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.8s.

LINK . SPRINGER . COM {}